SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors.

Merlo, M; Ammirati, E; Gentile, P; Artico, J; Cannatà, A; Finocchiaro, G; Barbati, G; Sormani, P; Varrenti, M; Perkan, A; et al. Merlo, M; Ammirati, E; Gentile, P; Artico, J; Cannatà, A; Finocchiaro, G; Barbati, G; Sormani, P; Varrenti, M; Perkan, A; Fabris, E; Aleksova, A; Bussani, R; Petrella, D; Cipriani, M; Raineri, C; Frigerio, M; Sinagra, G (2019) Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors. PLoS One, 14 (3). e0214616. ISSN 1932-6203 https://doi.org/10.1371/journal.pone.0214616
SGUL Authors: Finocchiaro, Gherardo

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

BACKGROUND: Persistent left ventricular (LV) systolic dysfunction in patients with acute lymphocytic myocarditis (LM) is widely unexplored. OBJECTIVES: To assess the frequency and predictors of persistent LV dysfunction in patients with LM and reduced LVEF at admission. METHODS AND RESULTS: We retrospectively evaluated 89 consecutive patients with histologically-proven acute myocarditis enrolled at three Italian referral hospitals. A subgroup of 48 patients with LM, baseline systolic impairment and an available echocardiographic assessment at 12 months (6-18) from discharge constituted the study population. The primary study end-point was persistent LV dysfunction, defined as LVEF <50% at 1-year, and was observed in 27/48 patients (56.3%). Higher LV end-diastolic diameter at admission (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.04-1.43, p = 0.002), non-fulminant presentation (OR 8.46, 95% CI 1.28-55.75, p = 0.013) and presence of a poor lymphocytic infiltrate (OR 12.40, 95% CI 1.23-124.97, p = 0.010) emerged as independent predictors of persistent LV dysfunction at multivariate analysis (area under the curve 0.91, 95% CI 0.82-0.99). Pre-discharge LVEF was lower in patients with persistent LV dysfunction compared to the others (32%±8 vs. 53%±8, p <0.001), and this single variable showed the best accuracy in predicting the study end-point (area under the curve 0.95, 95% CI 0.89-1.00). CONCLUSIONS: More than half of patients presenting with acute LM and LVEF <50% who survive the acute phase show persistent LV dysfunction after 1-year from hospital discharge. Features of subacute inflammatory process and of established myocardial damage at initial hospitalization emerged as predictors of this end-point.

Item Type: Article
Additional Information: © 2019 Merlo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: MD Multidisciplinary, General Science & Technology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: PLoS One
ISSN: 1932-6203
Language: eng
Dates:
DateEvent
28 March 2019Published
16 March 2019Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 30921422
Web of Science ID: WOS:000462594000099
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/110846
Publisher's version: https://doi.org/10.1371/journal.pone.0214616

Actions (login required)

Edit Item Edit Item